Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells. | J Optom | 2024 | 37788596 | PubTator, text mining | PubMed |
| A case of asymptomatic gastric plexiform fibromyxoma followed up for 3 years. | DEN Open | 2024 | 37731837 | PubTator, text mining | PubMed |
| Clinical, histopathological, and immunohistochemical spectrum of hepatolithiasis: a tertiary care center-based study from north India. | Virchows Arch | 2024 | 37550583 | PubTator, text mining | PubMed |
| Sclerosing epithelioid fibrosarcoma of bone with hybrid features: clinicopathologic, radiologic, and molecular analysis of three cases. | Skeletal Radiol | 2024 | 37524934 | PubTator, text mining | PubMed |
| Predictive markers for pathological complete response (pCR) after neo-adjuvant chemotherapy in HER2-positive breast carcinoma. | Histol Histopathol | 2024 | 37204204 | PubTator, text mining | PubMed |
| Low-grade fibromyxoid sarcoma of the orbit. | Orbit | 2024 | 36437749 | PubTator, text mining | PubMed |
| Comprehensive next-generation sequencing reveals low-grade fibromyxoid sarcoma of the vulva missed by morphological diagnosis: a case report. | Front Med (Lausanne) | 2023 | 38293297 | PubTator, text mining | PubMed |
| Dietary fiber pectin: challenges and potential anti-inflammatory benefits for preterms and newborns. | Front Nutr | 2023 | 38283907 | PubTator, text mining | PubMed |
| Topical Insulin in Neurotrophic Keratopathy: A Review of Current Understanding of the Mechanism of Action and Therapeutic Approach. | Pharmaceutics | 2023 | 38276493 | PubTator, text mining | PubMed |
| Application value of PET/CT in monophasic primary sacral synovial sarcoma: a case report and review of literature. | Front Oncol | 2023 | 38264744 | PubTator, text mining | PubMed |
| Response to Immunotherapy in Sclerosing Epithelioid Fibrosarcoma: Case Report and Literature Review. | Cureus | 2023 | 38259411 | PubTator, text mining | PubMed |
| Analysis of Somatic Mutations in the TCGA-LIHC Whole Exome Sequence to Identify the Neoantigen for Immunotherapy in Hepatocellular Carcinoma. | Curr Issues Mol Biol | 2023 | 38248311 | PubTator, text mining | PubMed |
| Adrenal Solitary Fibrous Tumor: A Case Report. | Cureus | 2023 | 38205453 | PubTator, text mining | PubMed |
| Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy. | Int J Mol Sci | 2023 | 38203175 | PubTator, text mining | PubMed |
| The Role of Cancer Stem Cell Markers in Ovarian Cancer. | Cancers (Basel) | 2023 | 38201468 | PubTator, text mining | PubMed |
| Case report: Primary pleural low-grade fibromyxoid sarcoma in a 4-year-old boy with molecular confirmation. | Front Oncol | 2023 | 38179169 | PubTator, text mining | PubMed |
| Club cell CREB regulates the goblet cell transcriptional network and pro-mucin effects of IL-1B. | Front Physiol | 2023 | 38173934 | PubTator, text mining | PubMed |
| Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion. | Ann Med | 2023 | 38163336 | PubTator, text mining | PubMed |
| The Current Role of Neoadjuvant Chemotherapy in the Management of HER2-Positive, Triple-Negative, and Micropapillary Breast Cancer: A Narrative Review. | Cureus | 2023 | 38161817 | PubTator, text mining | PubMed |
| The Expression of Mucin-4 (MUC4) in Sarcomas Apart From Sclerosing Epithelioid Fibrosarcoma and Low-Grade Fibromyxoid Sarcoma. | Cureus | 2023 | 38156143 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=14